Advances in the diagnosis and treatment of neuroblastoma.
about
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaAcquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomesHepatoblastoma metastatic to brain mimicking intracranial hemorrhage: Case report and literature review.The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.Ultrastructural features of neuroblastic tumours in relation to morphological, and molecular findings; a retrospective review study.Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma.Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction.Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastomaStridor in a newbornAtrophic upper pole of a duplex collecting system masquerading as suprarenal mass: a case study and literature review.Intermittent hypoxia effect on osteoclastogenesis stimulated by neuroblastoma cells.Treatment results and prognostic factors of pediatric neuroblastoma: a retrospective studyAcetaminophen induces human neuroblastoma cell death through NFKB activation.Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cellsPGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma.Distinct signatures of the immune responses in low risk versus high risk neuroblastomaFunctional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.Avoiding misdiagnosing neuroblastoma as Wilms tumorImaging in neuroblastoma: An update.Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology GroupThe significance of substance P in physiological and malignant haematopoiesisPeripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.Brain metastasis in children with stage 4 neuroblastoma after multidisciplinary treatment.Can Archival Tissue Reveal Answers to Modern Research Questions?: Computer-Aided Histological Assessment of Neuroblastoma Tumours Collected over 60 YearsEffect of indole ethyl isothiocyanates on proliferation, apoptosis, and MAPK signaling in neuroblastoma cell linesArtificial neural network classifier predicts neuroblastoma patients' outcomeImmunotherapy of neuroblastoma: present, past and future.Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma.Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition.The crucial role of tumour specimen handling in childhood cancer outcomesImmunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.Induction of Bex genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells.Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?Multiple roles of CD90 in cancer.Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers.2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells.Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma.
P2860
Q24186636-422FE1B8-8900-4D0F-9675-2BF538687135Q24200296-88A9BA0C-F83A-4D54-8DCB-E9242DA59764Q24235309-676358F2-FE53-46A1-8A35-100A4D1D1EDCQ30657233-5A36B0A4-25A0-40F8-98DD-136639DF2B36Q31109483-77217C9C-6724-41C1-9C4A-5E6C8C383097Q33510814-DDC12DAE-8C65-43B0-98C7-8D6D720ECD38Q33574489-FAB002FD-E87C-44A3-9A25-4CF1523BF595Q33618501-9E4A5DA5-12BB-493A-8728-2587E126A018Q33638474-B3735402-3DC1-45F6-B5CC-1C8B4A1E8565Q33909753-17A717E4-012E-408D-B667-46FACC86444CQ33939583-EA4B3EE4-E538-4592-BDCF-B3E4F0E1B14EQ34027896-EA15A9D8-C9B0-46C8-81EA-3234B7A70F07Q34078699-2ED5C328-511D-4FEB-BCD5-8B9FBD69CAD0Q34477899-984DB420-01A5-44EE-A4F9-2638ED27D488Q34483063-C9C5A028-4100-4390-9930-A2195F66B147Q35013101-A1BA7E01-65E5-4579-9122-8995AF77E621Q35078162-E1BA109E-F05F-4BFB-BD5E-DAE5BC1F3465Q35373780-C485FB02-AFE5-4554-B4FD-B82654CB2306Q35444381-57FC2D06-87EA-48C8-85B3-91B33374C7AFQ35546537-D9F2CD90-18AB-471F-BA1A-5F02D1398B3CQ35568727-32ABDC9F-F92A-43B5-8031-620DAE7FDA68Q36010031-481C7812-7DBC-4C34-A936-A39A02728B60Q36017182-6398DEB3-7F28-43A3-96A8-49EECBD0F4EDQ36096809-02976A79-92AB-4A61-9BBF-1103C1FF6402Q36121149-CAAC43D9-BBF6-4000-985E-E573A6A705EDQ36125822-2F73027A-B45F-44F6-9592-6A2E0C31228EQ36168388-4F9AC012-7354-4E3A-949D-D0D67F7D149AQ36276501-9D0A5198-8F67-4A54-89DB-2F00B9916F79Q36453273-5CE0CCC1-495A-4810-9613-B5D7A4098A05Q36845731-BF19930F-B2B0-4F6E-A921-15880F670183Q37287390-388CE44C-5C2A-41E6-83C4-C3D6DA83E03EQ37294008-6603BDBD-BABD-42A9-B866-809A73977F72Q37315226-A2A46417-AA47-48FE-AA00-AD6BB8E728E1Q37316127-85402981-21D3-4DCC-A0D9-B15A2D232B33Q37618138-630C686A-AB2D-4DB7-8A36-3E0C29A7F0C5Q38020759-833ACF58-B029-4EAD-AB93-3793F437E33BQ38805813-DB2120FA-AF19-45F7-877E-6A5CAAB22041Q38990860-6D145E1A-8826-45C2-8A43-5592489FDAE3Q39096682-BD69C008-CA9F-4368-9C97-ED2A08D0C8BAQ39113077-E638FF24-B437-46D6-9FF5-46319F85BD14
P2860
Advances in the diagnosis and treatment of neuroblastoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Advances in the diagnosis and treatment of neuroblastoma.
@ast
Advances in the diagnosis and treatment of neuroblastoma.
@en
Advances in the diagnosis and treatment of neuroblastoma.
@nl
type
label
Advances in the diagnosis and treatment of neuroblastoma.
@ast
Advances in the diagnosis and treatment of neuroblastoma.
@en
Advances in the diagnosis and treatment of neuroblastoma.
@nl
prefLabel
Advances in the diagnosis and treatment of neuroblastoma.
@ast
Advances in the diagnosis and treatment of neuroblastoma.
@en
Advances in the diagnosis and treatment of neuroblastoma.
@nl
P1433
P1476
Advances in the diagnosis and treatment of neuroblastoma.
@en
P2093
Howard M Katzenstein
Joanna L Weinstein
P304
P356
10.1634/THEONCOLOGIST.8-3-278
P577
2003-01-01T00:00:00Z